Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
small, motivated and development-focused team, and you will have the opportunity to work on a range of projects and with a wide range of stakeholders across the university. About the role: The Strategic
-
protocols and fabrication techniques as well as aiding them with process development. They will manage the scheduling of experiments, service engineer contracts, and maintain the process gases, chemicals, and
-
-based studies into early life development. This is a participant-facing role spanning perinatology and paediatrics, where you will manage a diverse mix of clinical, non-clinical, and administrative
-
parameter optimisation, stay engaged with developments in the ultra-high-field MRI literature, and contribute to the adaptation or development of novel acquisition techniques and sequences. Alongside
-
for the CEL Post Doctoral Research Associate, a 24-month appointment due to commence in September 2026. The role provides a development opportunity to an early career researcher with exceptional potential in
-
to high quality research and will be able to contribute excellent teaching to the development of our undergraduate and postgraduate programmes. You should hold a PhD in a relevant field, have academic
-
diagnostics and therapeutics, antimicrobials and respiratory medicines. In Medicines Development research group, we build on understanding of drugs to develop medicines of high safety and efficacy. We invite
-
mentoring and career development. The 2021 Research Excellence Framework (REF2021) placed King’s applied and allied health research 1st for: overall proportion of research rated 4* (world-leading, the best
-
health. The post holder will develop innovative AI techniques approaches applied to oral healthcare, with a particular focus on Large Language Model-based multimodal data understanding and reasoning
-
the development of new interfaces with teams across KCL. The applicant should have a strong, fundable research area that fits with the School of Cancer and Pharmaceutical Sciences and have obvious potential